Fig 1: Analysis of the inflammatory mediator concentrations in controls, patients with schizophrenia, and patients with schizophrenia after treatment. (A) A whole Western blot image, (B) IL-1β Western blot image, (C) IL-6 Western blot image, (D) TNF-α Western blot image, (E) quantitative determination of IL-1β expression, (F) quantitative determination of IL-6 expression, (G) quantitative determination of TNF-α expression. 1 and 7 = NC = normal control; 8 = D = D (CloZ) = patients with schizophrenia before clozapine treatment; 5 and 6 = CloZ = patients with schizophrenia after 6 months of clozapine treatment; 2 = D = D (OZ) = patients with schizophrenia before olanzapine treatment; 3 and 4 = OZ = patients with schizophrenia after 6 months of olanzapine treatment. @—significantly different in comparison to the NC group at p < 0.05, #—significantly different in comparison to the D (CloZ) group at p < 0.05, $—significantly different in comparison to the D (OZ) group at p < 0.05. Results are presented as the mean ± SEM (n = 12).
Fig 2: Determination of the inflammatory mediator concentrations in controls, schizophrenic patients, and schizophrenic patients following drugs administration. (A) A whole Western blot image, (B) Quantifications of Western Blots-stained IL-17 protein, (C) Quantifications of Western Blots-stained IL-6 protein, (D) Quantifications of Western Blots-stained TNF-α protein, (E) representative graph for IL-17 serum level, (F) representative graph for IL-6 serum level, (G) representative graph for TNF-α serum level. NC = normal control, schiz = D = patients with schizophrenia before treatment; HALP = HO = patients with schizophrenia after 6 months of haloperidol treatment, OLZ = OZ = patients with schizophrenia after 6 months of olanzapine treatment; OLZ + HALP = HO + OZ = patients with schizophrenia after 6 months of olanzapine treatment and haloperidol. @ significantly different in comparison to the control group, # significant different compared to OLZ (6 months), $ significant different compared to HALP (0 months Results are presented as the mean ± SEM (n = 12).
Supplier Page from Thermo Fisher Scientific for Recombinant Human IL-6 Protein